INVITATION FOR BID_Purchase of Lyophilizer at IVI

INVITATION FOR BID [Purchase of Lyophilizer at IVI]   The International Vaccine Institute (IVI) now invites sealed proposals from interested parties for the supply of the following goods and/or services:   Ref. No: IVI-DVT/2021-0715 Deadline for proposal submission: 17:00 on July 28, 2021, KST(GMT + […]

IVI to help developing countries tackle the spread of infectious diseases by building capacity through vaccinology training in Seoul

19th IVI International Vaccinology Course brings together 175 trainees and faculty members from 49 countries The annual course has trained over 1,544 healthcare professionals in vaccine development, evaluation, production and policy to help increase developing nations’ capacity in vaccine research and immunization.     September […]

IVI acquires supplemental funding for Severe Typhoid in Africa Program (SETA Plus)

  August 28, 2019 – SEOUL, South Korea – The International Vaccine Institute (IVI) has received additional funds of $4.33 million from the Bill & Melinda Gates Foundation to expand Severe Typhoid in Africa (SETA) Program activities in close alignment with the “Effect of a […]

‘Present and Future of Vaccine Development’ Seminar series: Genetic Engineering of Vibrio cholerae strains to fight against cholera

  August 23, SEOUL, South Korea. In our seminar series ‘Present and Future of Vaccine Development’, we were happy to welcome our latest speaker: Dr. Dong Wook Kim from the Department of Pharmacy at Hanyang University. Based upon their insight into the genetic alterations in […]